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Summary
Objective: To compare the metric properties and validity of German versions of the WOMAC (Western Ontario and
McMaster Universities) and a self-administered questionnaire-format of the Lequesne–Algofunctional–Index in
patients with osteoarthritis (OA) of the lower extremities.
Design: Cross-sectional analysis of the instruments’ internal consistency (Cronbach’s coefficient alpha) and
construct validity (correlation with radiological OA-severity and limitation in range-of-motion) in ambulatory patients
and patients before hip arthroplasty. Test–retest reliability was assessed on a subsample after 10 days.
Results: Data from 51 patients out of 91 contacted could be analyzed. Twenty-nine patients had knee and 22 patients
had hip OA. Both the WOMAC and Lequesne OA-indices and their scales or sections had a satisfactory test–retest
reliability (Intraclass correlation coefficient 0.43–0.96). All scales of the WOMAC were internally consistent
(Cronbach’s coefficient alpha 0.81–0.96) and associated with radiological OA-severity and joint range of motion.
However, only the function but not the symptom sections (Cronbach’s coefficient alpha knee: 0.55; hip: 0.63) of the
self-administered Lequesne OA index were internally consistent for both, patients with knee and hip OA. Also, the
symptom components were not or only weakly associated with radiological OA-severity and joint range of motion.
Conclusions: Although our results are based on a German version using a self-report format we may caution using
the self-administered Lequesne OA index without prior testing of its metric properties and validity.
Key words: Osteoarthritis, Health status, Clinimetrics, WOMAC, Lequesne.
Introduction
Comprehensive assessment of patients with osteo-
arthritis (OA) of the lower extremities includes
both measurement of impairment and disease
consequences to the patient [1–4]. There are a
variety of instruments that measure the different
dimensions of health status in patients with OA [5].
It has been suggested that the assessment should
include both disease specific and generic instru-
ments which cover distinct but important aspects
of patients’ health [6]. Probably the two most
widely used instruments for the assessment of
OA-specific health status are the Lequesne–Algo-
functional Indices for the hip [7–9] and the knee
[8–10] and the WOMAC (Western Ontario and
McMaster Universities) OA index [2, 4, 11–16].
Both instruments cover OA-specific symptoms and
physical functional disability. However, whereas
the WOMAC addresses symptoms and functional
disability in separate scales which may be
aggregated into a composite index the Lequesne
OA indices directly aggregate symptoms and
function which are not graded separately. Also, the
WOMAC is a patient questionnaire whereas the
Lequesne OA-index has been developed as an
interview format [2, 8–10].
The objective of our study was to compare the
metric properties and validity of German versions
of the WOMAC and a self-administered question-
naire format of the Lequesne OA index in patients
with OA of the lower extremities. We chose to test
a self-report format because in clinical trials it
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allows for mailing to patients and thus repeat
administration.
Methods
patients and data collection
Patients were recruited from the Departments of
Rheumatology and Orthopedic Medicine at the
University Hospital Basle. Patients who attended
the Rheumatology Department in 1994 and were
coded as having OA on a clinical registry were
mailed a postcard asking for participation in the
study. Patients who attended the orthopedics
department in May 1995 to undergo joint replace-
ment surgery where asked by the study physician
to participate in the study. Patients from the
rheumatology department were examined by a
medical student after training in standardized
clinical assessment whereas patients at the
orthopedics department were examined by the
study physician trained in standardized clinical
data assessment. Examination included assess-
ment of the combined clinical and radiological
classification criteria for OA [17, 18] using a
short-arm goniometer (degrees) [23]. After examin-
ation, patients were given the questionnaires.
Test–retest reliability was assessed on a random
subsample of patients recruited at the department
of rheumatology. Patients were provided with a
second questionnaire with the date of the second
administration marked (10 days after the visit and
completion of the baseline questionnaire). Patients
were instructed to complete the questionnaire at
the prespecified date and return the second
questionnaire in a preadressed envelope.
measures
The WOMAC is a three-dimensional measure of
pain, stiffness and physical functional disability
[2, 11–16]. The pain scale includes five questions
(S1–S5) asking about pain when ‘Walking on a flat
surface’ (S1), ‘Going up or down stairs’ (S2), ‘At
night while in bed’ (S3), ‘Sitting or lying’ (S4),
‘Standing upright’ (S5). The stiffness scale includes
two questions (St1, St2) asking about stiffness
‘after first awakening in the morning’ (St1) and
‘after sitting, lying or resting later in the day’ (St2).
The function scale (F1–F17) asks about the
degree of difficulty when ‘Descending stairs’,
‘Ascending stairs’, ‘Rising from sitting’, ‘Standing’,
‘Bending to floor’, ‘Walking on flat’, ‘Getting
in/out of car’, ‘Going shopping’, ‘Putting on
socks/stockings’, ‘Rising from bed’, ‘Taking off
socks/stockings’, ‘Lying in bed’, ‘Getting in/out of
bath’, ‘Sitting’, ‘Getting on/off toilet’, ‘Heavy
domestic duties’, ‘Light domestic duties’. Each of
the totally 24 questions is graded either on a Likert
scale or a visual analogue scale [2] ranging from
‘no’ to ‘extreme’. In this study we used a numerical
rating scale ranging from 0 to 10 which is the
preferred format in our population [19]. Similar
to the visual analogue scale it provides interval-
type data. To score each scale we calculated
the mean of the item scores. The results thus
equal standardized WOMAC scores (standardiz-
ation of WOMAC scores is by division of the
scale sum score by the number of items [2]). A
composite score was calculated as the unweighted
mean of the three scale scores. The scale scores
as well as the composite score thus range from 0
to 10.
The Lequesne OA index directly aggregates
symptoms and function which are not graded
separately. The index includes three sections with
a total of 10 questions and takes few minutes to
complete. For the purpose of this study we studied
the three sections separately. The first section
(1A–1E) asks about pain or discomfort ‘at night’
(1A), ‘after getting up in the morning’ (1B), ‘when
standing’ (1C) and ‘when walking’ (1D). The fifth
pain question (1E) addresses pain ‘when rising
from sitting’ (knee index) and pain when ‘sitting
2 h’ (hip index). Questions 1C and 1E are graded
dichotomously: 0 = no, 1 = yes. Questions 1A, 1B
and 1D have three categories with 0 = no; cat-
egories 1 and 2 are different for each question (1A:
1 = only with movement or in certain positions,
2 = with no movement; 1B: 1 = more than one but
less than 15 min, 2 = 15 min or more; 1D: 1 = only
after walking some distance, 2 = initially and
increasingly with continued walking). The second
section asks about the maximum walk distance
[graded from 0 = unlimited to 6 = less than 100 m
(328 ft)]. If patients use one or two walking aids the
score is upgraded by one and two points,
respectively. The third section addresses physical
function disability with four categories graded
from 0 = without difficulty to 2 = unable to do. The
knee index asks about ‘climbing one flight of stairs
upward’, ‘downward’, ‘squatting’ and ‘walking on
uneven ground’. The hip index asks about ‘putting
on socks’, ‘pick up an object on the floor’, ‘going up
or down one flight of stairs’, ‘getting out of a car
or a chair’. The Lequesne OA index is scored as the
sum of all questions. The score range of each
section is from 0 to 8 resulting in a total score
ranging from 0 to 24. The Lequesne OA index has
been developed using an interview format. Because
we were interested in comparing the performance
of the two most widely used OA-specific health
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status instruments using patient self-report useful
for clinical trials and epidemiologic research, we
adapted the Lequesne OA index for questionnaire
use (self-administered Lequesne OA Index). Specifi-
cally, we added a question about the use of walking
aids.
analyses
To assess whether the WOMAC and the
self-administered Lequesne OA index measure
similar constructs, we examined the correlations
between the instruments and their respective
symptom and function dimensions using Spear-
man’s rank correlation coefficient.
The internal consistency of the symptom and
function dimensions of both instruments was
examined using Cronbachs’ coefficient alpha
[20, 21] and inter-item correlations. To account for
the ordinal grading of the self-administered
Lequesne questions we used Spearman’s rank
correlation coefficient for the inter-item corre-
lation matrix.
Test–retest reliability of the indices and dimen-
sions was examined using the intraclass corre-
lation coefficient. To compare the construct
validity we examined the association of the scales
and sections with radiological OA-severity using
the method described by Kellgren and Lawrence
(grading from 0–4) [22] and range of motion using
a short-arm goniometer (degrees) [23]. For the knee
flexion and extension the deficit was recorded;
for the hip we used flexion and internal
rotation which have been found to be most




Data from 51 patients could be analyzed.
Thirty-seven out of 70 patients who were mailed
postcards participated in the study. One patient
died, one patient returned the postcard and denied
to participate and 29 patients did not return
the postcard. Two of the 37 patients did not fill in
the questionnaire leaving 35 questionnaires to be
analyzed. Nineteen out of 21 patients awaiting
surgery agreed to participate. However, the data of
three patients was incomplete and they were
excluded from the study leaving 16 questionnaires
for the analysis. All 12 out of 13 patients who
agreed to fill in a second questionnaire after 10
days returned the questionnaire between 11 and 14
days.
The mean age of the patients was 70 (standard
deviation 13.4). Sixty-seven percent of the patients
were female. Twenty-nine patients had knee OA
and 22 patients had hip OA. All patients fulfilled
the ACR criteria for hip or knee OA [17, 18].
Radiological OA-severity and limitations in range
of motion are shown in Table IV.
analyses
Correlation between scales (Table I)
There was a moderate to high correlation
between the WOMAC and self-administered
Lequesne OA-indices for both the knee and hip. As
expected, there was a higher correlation between
the respective symptom and function dimensions
than across dimensions.
Table I
Spearman’s rank correlation between the self-administered Lequesne and WOMAC scales
WOMAC Knee WOMAC Hip
Composite Pain Stiffness Function Composite Pain Stiffness Function
Lequesne knee
Composite 0.65 0.52† 0.61† 0.72
Pain 0.68† 0.66† 0.59† 0.66†
Walk 0.26 0.17 0.25 0.32
Function 0.63† 0.52† 0.51† 0.72†
Lequesne hip
Composite 0.82† 0.66† 0.79† 0.87†
Pain 0.69† 0.68† 0.70† 0.61†
Walk 0.68† 0.51* 0.61† 0.79†
Function 0.73† 0.49* 0.69† 0.77†
PQ 9[94[
$PQ 9[90[
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Table II
Metric properties of the WOMAC and self-administered Lequesne indices
Internal Intraobserver
consistency reliability
Score scale* Item-scale correlation† scale‡ Items‡
Lequesne knee
Composite 11.0 (4.5) 0.82 0.19–0.81 0.86 —
Pain 4.5 (1.7) 0.55 0.18–0.43 0.87 0.14–1.00
Function 4.0 (2.0) 0.86 0.62–0.76 0.92 0.40–1.00
Lequesne hip
Composite 11.4 (5.4) 0.83 0.24–0.91 0.94 —
Pain 4.5 (2.1) 0.63 0.25–0.57 0.96 0.58–1.00
Function 3.9 (1.8) 0.84 0.53–0.81 0.85 0.76–0.87
WOMAC knee
Composite 4.0 (2.5) — — 0.83 —
Pain 3.9 (2.8) 0.89 0.53–0.81 0.90 0.52–0.94
Stiffness 4.0 (3.2) 0.93 0.87 0.72 0.65–0.69
Function 4.1 (2.5) 0.96 0.54–0.86 0.71 0.22–0.96
WOMAC hip
Composite 4.6 (2.7) — — 0.77 —
Pain 4.4 (2.6) 0.82 0.47–0.64 0.79 0.48–0.86
Stiffness 4.6 (3.2) 0.81 0.68 0.43 0.41–0.48
Function 4.7 (2.7) 0.96 0.51–0.86 0.93 0.45–0.97
Cronbach|s coef_cient alpha[
%Intraclass correlation coef_cient[
$Correlations are computed with the item of interest deleted[
Internal consistency (Table II, III)
All WOMAC scales had a high Cronbach’s
coefficient alpha ranging from 0.81–0.96 for both
the hip and the knee. The inter-item correlations
and item-correlation with the scale score were
significant, moderate to strong, indicating that the
WOMAC scales are measures of the underlying
constructs pain, stiffness and physical function.
An equally high internal consistency with Cron-
bach alpha’s of 0.84 and 0.86 and significant,
moderate to strong, inter-item correlations were
found for the function sections of both the
self-administered knee and the hip Lequesne OA
indices. There were, however, low Cronbach’s
coefficients alpha of 0.55 and 0.63 for the symptom
sections of both the knee and the hip. In
some instances inter-item correlations were
negative. There was a correlation of r = −0.10
between ‘pain at night’ and ‘pain after getting
up in the morning’ in patients with hip OA
whereas the correlation of ‘pain at night’ and
‘pain while standing’ in patients with knee OA
was r = −0.07. Overall there was no consistent
association among the symptom items and between
the symptom and function items. This indicates
that neither the symptom section nor the com-
posite index which integrates the symptom and
function items are unidimensional measures
[21, 24].
Intraobserver reliability (Table II)
Using the intraclass correlation coefficient,
there was a good test–retest reliability for both
indices. The test–retest reliability of the dimen-
sions was generally higher for the self-adminis-
tered Lequesne OA index than for the WOMAC.
For the hip, the reliability of the WOMAC stiffness
scale was only 0.43 which is weak. One may note,
that the WOMAC stiffness scale consists of only
two questions which may result in a less stable
estimate.
Construct validity (Table IV)
As hypothesized we found moderate, significant
correlations of the WOMAC and self-administered
Lequesne OA index with radiological OA severity
and range of motion for both, patients with hip and
knee OA. For both indices there were generally
higher correlations for the function dimensions
(including walking distance for the self-adminis-
tered Lequesne OA index) than for the symptom
scales. A lack of significant association with the
biological parameters was, however, found for the
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Table III
Spearman’s rank correlation between the items of the self-administered Lequesne index (row 1: knee; row 2: hip)
Walk
Pain distance Function
Items 1B 1C 1D 1E 2 3A 3B 3C 3D
Pain 1A −0.08 −0.07 0.20 0.41* 0.08 0.23 0.04 0.39* 0.23
−0.10 0.11 0.20 0.47* 0.05 0.14 0.35 −0.02 0.35
1B 0.41* 0.20 0.33 −0.04 0.19 0.31 0.36 0.58†
0.15 0.51* 0.24 0.62† 0.20 0.39 0.64† 0.67†
1C 0.15 −0.01 0.08 0.13 0.08 0.29 0.51†
0.21 0.26 −0.15 0.21 0.25 0.01 0.20
1D 0.22 0.32 0.46* 0.44* 0.17 0.52†
0.40 0.34 0.09 0.38 0.22 0.42
1E 0.24 0.59† 0.49† 0.24 0.39*
0.14 0.18 0.41 −0.04 0.36
Walk distance 2 0.72† 0.60† 0.46* 0.50†
0.41 0.53* 0.70† 0.77†








symptom section of the self-administered Lequesne
OA index.
Discussion
The WOMAC and the self-administered
Lequesne OA index are two highly related
disease-specific measures of symptom severity and
physical functional disability in patients with OA
of the lower extremities. With the exception of the
WOMAC stiffness scale in patients with hip OA
which had a weak intraobserver reliability both
instruments and subscales had a satisfactory
intraobserver reliability.
All three WOMAC scales had a good internal
consistency. The internal consistency of the
WOMAC scales was comparable (Cronbach al-
pha’s of q0.8) to the results from previous work by
Bellamy summarized in the user’s guide to the
WOMAC [4]. Instead, only the physical function
sections of the self-administered Lequesne but not
the symptom sections and thus the composite
indices which integrate symptom and physical
function items were internally consistent. As to the
best of our knowledge there are no previous data
on the internal consistency of the Lequesne OA
index, so we can not put our data in perspective.
The internal consistency did not reach the minimal
requirements for group comparisons by Nunally
[21]. This was found for both, knee and hip OA. In
other words, the symptom section and thus the
composite self-administered Lequesne OA index
are not unidimensional measures of an underlying
construct [21, 24]. Assuming identical physical
function we may not conclude that patients with a
higher score on the symptom section have more
severe symptoms then patients with a lower score.
Interestingly, the symptom section of the
self-administered Lequesne OA index for both hip
and knee OA was not or only weakly correlated
with radiological OA severity and limitations of
range of motion whereas the WOMAC pain scale
was a moderate significant correlate of these
parameters. This is further evidence that the
symptom section of the self-administered Lequesne
OA index was not a reliable measure of pain in
patients with OA of the lower extremities. It is
interesting that the assocation between the
WOMAC and the impairment parameters was low
for the knee while it was moderate for the hip. This
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Table IV
Correlation of the WOMAC and self-administered Lequesne scales with radiology [22] and range of motion
Correlation of radiology and range of motion with
Mean (Std) Pain Stiffness Walk distance Function Composite
Lequesne knee (N = 29)
Kellgren (0–4) 2.5 (0.9) 0.10 — 0.42† 0.59‡ 0.47‡
Flexion (°) 123 (21) −0.16 — −0.48† −0.62‡ −0.51‡
Extension deficit (°) 7 (6) 0.37† — 0.17 0.38† 0.39†
Lequesne hip (N = 22)
Kellgren (0–4) 3.2 (0.9) 0.18 — 0.42† 0.46† 0.37
Flexion (°) 96 (26) −0.09 — −0.34 −0.29 −0.25
Internal rotation (°) 9 (17) −0.13 — −0.43 −0.31 −0.34
WOMAC knee (N = 29)
Kellgren (0–4) 2.5 (0.9) 0.28 0.24 — 0.44† 0.34
Flexion (°) 123 (21) −0.27 −0.36† — −0.54‡ −0.44†
Extension deficit (°) 7 (6) 0.42† 0.33 — 0.45† 0.38†
WOMAC hip (N = 22)
Kellgren (0–4) 3.2 (0.9) 0.73‡ 0.46† — 0.61‡ 0.67‡
Flexion (°) 96 (26) −0.47† −0.27 — −0.43 −0.44†
Internal rotation (°) 9 (17) −0.51† −0.33 — −0.47† −0.49†
Spearman|s rank correlations coef_cient[
$PQ 9[94[
%PQ 9[90[
is consistent with a weaker association between
radiology and range of motion in knee as compared
to hip OA [24]. Hip and knee OA are two clinically
distinct entities which need to be assessed in a
specific manner with respect to both, clinical and
health outcomes.
There are different possible explanations for
the lack of internal consistency and validity of the
symptom section of the self-administered Lequesne
OA index tested in our study. First, we used a
German adaptation of the French original using a
self-report format instead of an interview. Because
we performed a cultural adaptation following the
recently published guidelines [25, 26] including
translation and backtranslation procedures and
committee review which revealed no particular
problems [27, 28] translation is an unlikely cause.
The fact that most patients consistently filled in
the questionnaire and the good intraobserver
reliability of the symptom items also makes the
different format an unlikely explanation. Second,
the grading of the self-administered Lequesne
symptom questions which follows different con-
cepts such as ‘presence of pain’, ‘pain with
movement’, ‘duration of pain’ and ‘appearance of
pain after a certain period of time’ may explain the
lack of correlation among the symptom items.
Consistent with clinical experience our results
suggest that one may not assume that patients with
‘pain at night without movement’ (as compared
with ‘pain only on movement or in certain
positions’) are more likely to experience ‘pain for
more than 15 min after getting up in the morning’
(as compared with ‘pain for 1–15 min’) and to have
‘immediate pain with walking’ (as compared with
‘pain only after a certain distance’). The sugges-
tion that the grading of the self-administered
Lequesne symptom items is responsible for the lack
of internal consistency is supported by the high
internal consistency of comparable WOMAC items
consistently graded from ‘no pain’ to ‘extreme
pain’. To the best of our knowledge, there is no
report on the internal consistency of the Lequesne
symptom questions. It is thus not possible to decide
whether the lack of internal consistency was a
problem specific to our population and the
self-report format or of the self-administered
Lequesne OA indices in general.
To compare the two indices we made two
assumptions. First, based on the data from the
development of the WOMAC [4], current concepts
of condition specific measurement in general [29]
and clinical face validity we assumed that there
are two distinct, although related, dimensions of
condition specific health: pain and function. Since
we did not question this assumption we did not
perform a factor analysis but analyzed the two
dimensions separately. We therefore analyzed the
symptom and function section of the Lequesne OA
index separately although the index uses an
overall score. Because there is no published data
on the internal consistency of the composite index
we can not put our results in perspective. However,
because the analysis of internal consistency of
both the symptoms and function items does not
increase the lack of association among the
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symptom items, it is unlikely that our separate
analysis of the symptom and function sections does
question our conclusion.
A limitation of our study is the relatively small
sample size and the selection of patients from a
rheumatology registry and an orthopedics depart-
ment. Although all patients fulfilled the ACR OA
criteria, the study sample is unlikely to be
representative for the whole spectrum of OA
patients. In another sample the result may thus be
different.
Summarizing the results of our comparison of
the WOMAC and the self-administered Lequesne
OA indices, we found the WOMAC to have good
metric properties and validity whereas the symp-
tom section of the self-administered Lequesne OA
index and thus the composite index were neither
internally consistent nor valid. The most likely
reason for the lack of consistency among the
symptom items is the inconsistent grading along
different dimensions. Although our results are
based on a German version using a self-report
format we may caution using the self-administered
Lequesne OA index without prior testing of its
metric properties and validity.
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